Products for Research Use Only
RegisterLogin

CDK9-IN-44

CAT: 0013-GTR19273317-01Size: 50 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19273317-01Size:50 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
CDK9-IN-44 (Compound 7) is a selective inhibitor of CDK9 with an IC50 of 7.6 μM. It effectively inhibits CDK9/cyclin T1 kinase activity, impedes transcription elongation, reduces the expression of oncogenic proteins such as MCL1 and c-MYC, and induces apoptosis in tumor cells. CDK9-IN-44 shows potential for research in glioblastoma (GBM) and central nervous system (CNS) diseases.
Storage Conditions
-20°C
Notes
For research use only.

Related Products

CatalogName
GTR19258506-01CDK2-IN-44
GTR18308618CDK9-55/CDK9 Rabbit Polyclonal Antibody
GTR19206276-01CDK9-IN-10
GTR17918794-01CDK9 Antibody
GTR18593597-01CDK9 Antibody
GTR18580918-01CDK9 Antibody
GTR19243952-01CDK9-IN-15
GTR19235891-01CDK9-IN-31
GTR19231013-01CDK9-IN-27
GTR19230339-01CDK9-IN-28

Alternative Products

CatalogName
HY-178499CDK9-IN-44
030081CDK9
JH1809444'44'
BA3838-50CDK9-IN-10
BA3826-1CDK9-IN-13
BA2986-1CDK9-IN-7
BA3853-10CDK9-IN-14
HY-179023CDK9-IN-45
HY-176736CDK9-IN-40
HY-173481CDK9-IN-37

Popular Products